Background MicroRNAs (miRNAs) are important in hepatic pathophysiology and the
development of liver cancer. Objective To explore miRNAs that are regulated with the progression …

Background Screening and prophylactic treatment for hepatitis B virus (HBV) reactivation is
recommended for patients who receive immunosuppressive or cytotoxic therapy. The aim of …

Background Although histopathological examination by “invasive” liver biopsy remains the
gold standard for evaluating disease progression in chronic liver disease, noninvasive tools …

Background It is unclear whether tenofovir disoproxil fumarate and entecavir differ in their
association with risk of hepatocellular carcinoma in patients with chronic hepatitis B, and …

Aim The association between sarcopenia and nutritional status is thought to be an important
problem in patients with cirrhosis. In this study, we investigated whether nutritional factors …

Background Long-term incidences and baseline determinants of functional cure (hepatitis B
surface antigen [HBsAg] seroclearance) during entecavir (ETV) or tenofovir disoproxil …

Background & Aims The effect of hepatocellular carcinoma (HCC) on the response to
interferon-free direct-acting antiviral (DAA) therapy in patients with chronic hepatitis C (CHC) …

METHODS: This retrospective cohort study analyzed an international consortium that
encompassed 19 centers from 6 countries or regions composed of previously untreated CHB …

MicroRNA (miRNA) expression profiling has proven useful in diagnosing and understanding
the development and progression of several diseases. Microarray is the standard method …

Background Patients on oral antiviral (OAV) therapy remain at hepatocellular carcinoma (HCC)
risk. Risk prediction tools distinguishing treated patients with residual HCC risk are …